Join to view full profile
1150 NW 72nd Ave Ste Ph1Miami, FL 33126
Phone+1 305-701-9901
Fax+1 305-701-9902
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nicholas Suite, MD is a board certified neurologist in Miami, Florida. He is currently licensed to practice medicine in Florida, Virginia, and Michigan.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1989 - 1991- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1986 - 1989
Johns Hopkins University School of MedicineClass of 1986
Certifications & Licensure
FL State Medical License 1991 - 2027
VA State Medical License 2025 - 2026- FL State Medical License 1991 - 2025
MI State Medical License 2006 - 2022
NY State Medical License 1987 - 1992
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 26 citationsPrevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic events.Denise Barbut, Jeffrey S. Borer, Azuddin Gharavi, Donald C. Wallerson, Richard B. Devereux
The American Journal of Cardiology. 1992-10-01 - 3 citationsNonconvulsive Generalized Status Epilepticus and AIDSMeng C. Wong, Nicholas D. A. Suite, Douglas R. Labar
Annals of Internal Medicine. 1992-01-15 - 98 citationsSeizures in Human Immunodeficiency Virus InfectionMeng C. Wong, Nicholas D. A. Suite, Douglas R. Labar
Archives of Neurology. 1990-06-01
Press Mentions
Patchwork System for Rationing a Covid Drug Sends Immunocompromised Patients on a ‘Hunger Games Hunt’January 27th, 2022- Florida to Prioritize Transplant Hospitals, Cancer Centers for Scarce COVID-19 TherapeuticJanuary 18th, 2022
